Literature DB >> 26335890

Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making.

Elisa F Long1, Patricia A Ganz2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26335890     DOI： 10.1001/jamaoncol.2015.2340

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  16 in total

Review 1.  Population genetic testing for cancer susceptibility: founder mutations to genomes.

Authors:  William D Foulkes; Bartha Maria Knoppers; Clare Turnbull
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

2.  Persistent Underutilization of BRCA1/2 Testing Suggest the Need for New Approaches to Genetic Testing Delivery.

Authors:  Anne Marie McCarthy
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

Review 3.  Precisely Where Are We Going? Charting the New Terrain of Precision Prevention.

Authors:  Karen M Meagher; Michelle L McGowan; Richard A Settersten; Jennifer R Fishman; Eric T Juengst
Journal:  Annu Rev Genomics Hum Genet       Date:  2017-04-24       Impact factor: 8.929

4.  Use of BRCA Mutation Test in the U.S., 2004-2014.

Authors:  Fangjian Guo; Jacqueline M Hirth; Yu-Li Lin; Gwyn Richardson; Lyuba Levine; Abbey B Berenson; Yong-Fang Kuo
Journal:  Am J Prev Med       Date:  2017-03-22       Impact factor: 5.043

5.  National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.

Authors:  Christopher P Childers; Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko
Journal:  J Clin Oncol       Date:  2017-08-18       Impact factor: 44.544

6.  Population Testing for High Penetrance Genes: Are We There Yet?

Authors:  Nicolas Wentzensen; Christine D Berg
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

7.  A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.

Authors:  Ana F Best; Margaret A Tucker; Megan N Frone; Mark H Greene; June A Peters; Hormuzd A Katki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-28       Impact factor: 4.254

8.  A simple framework to identify optimal cost-effective risk thresholds for a single screen: Comparison to Decision Curve Analysis.

Authors:  Hormuzd A Katki; Ionut Bebu
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2021-03-23       Impact factor: 2.175

9.  Population-Based BRCA1/2 Testing in Ashkenazi Jews: Ready for Prime Time.

Authors:  Filipa Lynce; Claudine Isaacs
Journal:  J Natl Compr Canc Netw       Date:  2016-06       Impact factor: 11.908

10.  Comments on "Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns".

Authors:  Andrew Brane; Michael Behring; Karina I Halilova; Lyse Norian
Journal:  Int J Cancer       Date:  2021-05-06       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.